Bessemer Group Inc Glaukos Corp Transaction History
Bessemer Group Inc
- $61.6 Billion
- Q2 2025
A detailed history of Bessemer Group Inc transactions in Glaukos Corp stock. As of the latest transaction made, Bessemer Group Inc holds 6,542 shares of GKOS stock, worth $558,228. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,542
Previous 276
2270.29%
Holding current value
$558,228
Previous $27,000
2400.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GKOS
# of Institutions
332Shares Held
54.3MCall Options Held
259KPut Options Held
481K-
Black Rock Inc. New York, NY8.04MShares$686 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$522 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$277 Million0.06% of portfolio
-
State Street Corp Boston, MA2.09MShares$178 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2MShares$171 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.06B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...